SpyGlass Pharma, Inc. (SGP) shares outstanding
SpyGlass Pharma, Inc. (SGP) had 31.91M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 77.7% higher than the 17.96M of fiscal 2024. Figures as of 18 Nov 2026, 11:34 UTC, from Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2025
- 31.91M
- Change on fiscal 2024
- +77.7%
- Highest on record
- 31.91Mfiscal 2025
- Lowest on record
- 11.40Mfiscal 2023
- Fiscal years on record
- 32023–2025
Figures as of . Statements from Yahoo Finance. Figures, not advice.
SpyGlass Pharma, Inc. shares outstanding, in more detail
The market data feed counts 33.46M shares outstanding today.
Across the 3 fiscal years on record (2023–2025), the highest was 31.91M in fiscal 2025 and the lowest 11.40M in fiscal 2023.
Shares outstanding by fiscal year
SpyGlass Pharma, Inc. shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2025 | 31.91M | 77.7% up | |
| 2024 | 17.96M | 57.5% up | |
| 2023 | 11.40M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
SpyGlass Pharma, Inc., figure by figure
- SpyGlass Pharma, Inc. market cap
- SpyGlass Pharma, Inc. revenue
- SpyGlass Pharma, Inc. earnings
- SpyGlass Pharma, Inc. earnings per share (EPS)
- SpyGlass Pharma, Inc. P/E ratio
- SpyGlass Pharma, Inc. P/S ratio
- SpyGlass Pharma, Inc. P/B ratio
- SpyGlass Pharma, Inc. free cash flow
- SpyGlass Pharma, Inc. operating margin
- SpyGlass Pharma, Inc. dividend
- SpyGlass Pharma, Inc. total debt
- SpyGlass Pharma, Inc. cash on hand
- SpyGlass Pharma, Inc. total assets
- SpyGlass Pharma, Inc. return on equity (ROE)
- SpyGlass Pharma, Inc. return on invested capital (ROIC)
SpyGlass Pharma, Inc. (SGP) overview: price, valuation and scorecard
SpyGlass Pharma, Inc. shares outstanding: questions and answers
How many shares does SpyGlass Pharma, Inc. have?
SpyGlass Pharma, Inc. (SGP) had 31.91M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 77.7% higher than the 17.96M of fiscal 2024. The market data feed counts 33.46M shares outstanding today.
What are the highest and lowest diluted share count figures on record for SpyGlass Pharma, Inc.?
Across the 3 fiscal years on record (2023–2025), the highest was 31.91M in fiscal 2025 and the lowest 11.40M in fiscal 2023.
How is SpyGlass Pharma, Inc.'s diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For SpyGlass Pharma, Inc. it is on record here for 3 fiscal years, 2023 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “SpyGlass Pharma, Inc. (SGP) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/SGP/shares-outstanding
Underlying data: Yahoo Finance.